Exosome-mediated Drug Resistance in Cancer: the Near Future is Here

Overview

Journal Ther Adv Med Oncol

Specialty Oncology

Date 2016 Sep 2

PMID 27583023

Citations 25

Authors

Marco Giallombardo

Simona Taverna

Riccardo Alessandro

David Hong

Christian Rolfo

Affiliations

Soon will be listed here.

Citing Articles

Revolution in Cancer Treatment: How Are Intelligently Designed Nanostructures Changing the Game?.

Gul D, Onal Acet B, Lu Q, Stauber R, Odabasi M, Acet O Int J Mol Sci. 2024; 25(10).

PMID: 38791209 PMC: 11120744. DOI: 10.3390/ijms25105171.

Chu D, Chen L, Li W, Zhang H Clin Exp Med. 2024; 24(1):104.

PMID: 38761234 PMC: 11102376. DOI: 10.1007/s10238-024-01319-x.

An exosome mRNA-related gene risk model to evaluate the tumor microenvironment and predict prognosis in hepatocellular carcinoma.

Du Z, Han X, Zhu L, Li L, Castellano L, Stebbing J BMC Med Genomics. 2024; 17(1):86.

PMID: 38627727 PMC: 11020893. DOI: 10.1186/s12920-024-01865-z.

Research progress of exosomes in drug resistance of breast cancer.

Liu L, Jiang D, Bai S, Zhang X, Kang Y Front Bioeng Biotechnol. 2024; 11:1214648.

PMID: 38239920 PMC: 10794616. DOI: 10.3389/fbioe.2023.1214648.

Exosomal Linc00969 induces trastuzumab resistance in breast cancer by increasing HER-2 protein expression and mRNA stability by binding to HUR.

Liu C, Lu C, Yixi L, Hong J, Dong F, Ruan S Breast Cancer Res. 2023; 25(1):124.

PMID: 37848981 PMC: 10580635. DOI: 10.1186/s13058-023-01720-6.

References

Fontana S, Simona F, Saieva L, Laura S, Taverna S, Simona T . Contribution of proteomics to understanding the role of tumor-derived exosomes in cancer progression: state of the art and new perspectives. Proteomics. 2013; 13(10-11):1581-94. DOI: 10.1002/pmic.201200398. View

Challagundla K, Wise P, Neviani P, Chava H, Murtadha M, Xu T . Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy. J Natl Cancer Inst. 2015; 107(7). PMC: 4651042. DOI: 10.1093/jnci/djv135. View

Chen W, Cai Y, Lv M, Chen L, Zhong S, Ma T . Exosomes from docetaxel-resistant breast cancer cells alter chemosensitivity by delivering microRNAs. Tumour Biol. 2014; 35(10):9649-59. DOI: 10.1007/s13277-014-2242-0. View

Ciravolo V, Huber V, Ghedini G, Venturelli E, Bianchi F, Campiglio M . Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy. J Cell Physiol. 2011; 227(2):658-67. DOI: 10.1002/jcp.22773. View

Rolfo C, Castiglia M, Hong D, Alessandro R, Mertens I, Baggerman G . Liquid biopsies in lung cancer: the new ambrosia of researchers. Biochim Biophys Acta. 2014; 1846(2):539-46. DOI: 10.1016/j.bbcan.2014.10.001. View

Safaei R, Larson B, Cheng T, Gibson M, Otani S, Naerdemann W . Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells. Mol Cancer Ther. 2005; 4(10):1595-604. DOI: 10.1158/1535-7163.MCT-05-0102. View

Putz U, Howitt J, Doan A, Goh C, Low L, Silke J . The tumor suppressor PTEN is exported in exosomes and has phosphatase activity in recipient cells. Sci Signal. 2012; 5(243):ra70. DOI: 10.1126/scisignal.2003084. View

Wei Y, Lai X, Yu S, Chen S, Ma Y, Zhang Y . Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells. Breast Cancer Res Treat. 2014; 147(2):423-31. DOI: 10.1007/s10549-014-3037-0. View

Kowal J, Tkach M, Thery C . Biogenesis and secretion of exosomes. Curr Opin Cell Biol. 2014; 29:116-25. DOI: 10.1016/j.ceb.2014.05.004. View

10.

Milane L, Singh A, Mattheolabakis G, Suresh M, Amiji M . Exosome mediated communication within the tumor microenvironment. J Control Release. 2015; 219:278-294. DOI: 10.1016/j.jconrel.2015.06.029. View

11.

Lv M, Zhu X, Chen W, Zhong S, Hu Q, Ma T . Exosomes mediate drug resistance transfer in MCF-7 breast cancer cells and a probable mechanism is delivery of P-glycoprotein. Tumour Biol. 2014; 35(11):10773-9. DOI: 10.1007/s13277-014-2377-z. View

12.

Steelman L, Navolanic P, Sokolosky M, Taylor J, Lehmann B, Chappell W . Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors. Oncogene. 2008; 27(29):4086-95. PMC: 3836277. DOI: 10.1038/onc.2008.49. View

13.

Pink R, Samuel P, Massa D, Caley D, Brooks S, Carter D . The passenger strand, miR-21-3p, plays a role in mediating cisplatin resistance in ovarian cancer cells. Gynecol Oncol. 2015; 137(1):143-51. DOI: 10.1016/j.ygyno.2014.12.042. View

14.

Corcoran C, Rani S, OBrien K, ONeill A, Prencipe M, Sheikh R . Docetaxel-resistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomes. PLoS One. 2012; 7(12):e50999. PMC: 3519481. DOI: 10.1371/journal.pone.0050999. View

15.

Chen W, Liu X, Lv M, Chen L, Zhao J, Zhong S . Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs. PLoS One. 2014; 9(4):e95240. PMC: 3989268. DOI: 10.1371/journal.pone.0095240. View

16.

Ji R, Zhang B, Zhang X, Xue J, Yuan X, Yan Y . Exosomes derived from human mesenchymal stem cells confer drug resistance in gastric cancer. Cell Cycle. 2015; 14(15):2473-83. PMC: 4613597. DOI: 10.1080/15384101.2015.1005530. View